Deloitte Recap Conference, Tuesday-Wednesday, May 25-26, 2010
Topic: Deloitte Recap Conference, Tuesday-Wednesday, May 25-26, 2010
Topic: Allicense 2010: Redefining the Threshold of Innovation
Date and Time: Tue, May 25 to Wed, May 26
Location: Fairmont Hotel, San Francisco, CA,
http://www.recap.com/88256AFE0004ABF3/allicense
Cost: Standard Registration - Register on/after March 1, 2010-$1,950.00
"Team" Discount Registration: Register 2 or more from your company for 25% off each. (Price based on registration date)
Registration fee includes 2 days of conference sessions, continental breakfasts and seated luncheons on both days, and attendance to the Breakthrough Alliance Awards Dinner on May 25, 2010.
Conference Description
The Allicense conference is a must-attend event for hundreds of biotech and Pharma executives The conference includes presentations and panel discussions on leading practices in business development and biotech finance, allowing executives to expand business connections and gain an in-depth perspective into current industry trends
The two day agenda will include:
• Keynote presentations from Bernard Munos (Lilly) and John Mendlein (Fate Therapeutics)
Bernard Munos, Advisor for Corporate Strategy, Eli Lilly
Will be providing insights on innovation in the Biopharma industry, followed by a roundtable of leading Pharma executives discussing organizational models designed to speed decision making and avoid failures.
John Mendlein, Chairman, Fate Therapeutic
Will share insights on how to successfully develop disruptive technologies.
David Stump, CSO, Human Genome Sciences
Will share insights into successful late-stage clinical development. Find out the keys to HGSI's success while so many other companies and products have failed.
• Panel sessions featuring buy-side and sell-side views of the marketplace
Panel sessions will be offered throughout the two-day event. Learn from panels of experienced industry experts about current issues and trends for Biotech and have an opportunity to network with the speakers and attendees.
Deal Making from the Pharma Perspective
Pharma Search & Evaluation
Biotech Transaction Process
Pharma Organizational Structures
Biotech CEO Panel
Outlook Panel
• Clinical Panel
• Networking opportunities to meet and interact with leading executives
• The Allicense Award Dinner and presentation of the Breakthrough Alliance Award
Date and Time: Tue, May 25 to Wed, May 26
Location: Fairmont Hotel, San Francisco, CA,
http://www.recap.com/88256AFE0004ABF3/allicense
Cost: Standard Registration - Register on/after March 1, 2010-$1,950.00
"Team" Discount Registration: Register 2 or more from your company for 25% off each. (Price based on registration date)
Registration fee includes 2 days of conference sessions, continental breakfasts and seated luncheons on both days, and attendance to the Breakthrough Alliance Awards Dinner on May 25, 2010.
Conference Description
The Allicense conference is a must-attend event for hundreds of biotech and Pharma executives The conference includes presentations and panel discussions on leading practices in business development and biotech finance, allowing executives to expand business connections and gain an in-depth perspective into current industry trends
The two day agenda will include:
• Keynote presentations from Bernard Munos (Lilly) and John Mendlein (Fate Therapeutics)
Bernard Munos, Advisor for Corporate Strategy, Eli Lilly
Will be providing insights on innovation in the Biopharma industry, followed by a roundtable of leading Pharma executives discussing organizational models designed to speed decision making and avoid failures.
John Mendlein, Chairman, Fate Therapeutic
Will share insights on how to successfully develop disruptive technologies.
David Stump, CSO, Human Genome Sciences
Will share insights into successful late-stage clinical development. Find out the keys to HGSI's success while so many other companies and products have failed.
• Panel sessions featuring buy-side and sell-side views of the marketplace
Panel sessions will be offered throughout the two-day event. Learn from panels of experienced industry experts about current issues and trends for Biotech and have an opportunity to network with the speakers and attendees.
Deal Making from the Pharma Perspective
Pharma Search & Evaluation
Biotech Transaction Process
Pharma Organizational Structures
Biotech CEO Panel
Outlook Panel
• Clinical Panel
• Networking opportunities to meet and interact with leading executives
• The Allicense Award Dinner and presentation of the Breakthrough Alliance Award
